#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0192] In another embodiment, a transgastric fastening assembly may be required at the region of the cardia 402 to treat morbid obesity in a similar manner to that utilized with the LAP-BAND.TM.
1-1	0-1	[	_	_	
1-2	1-5	0192	_	_	
1-3	5-6	]	_	_	
1-4	7-9	In	_	_	
1-5	10-17	another	_	_	
1-6	18-28	embodiment	_	_	
1-7	28-29	,	_	_	
1-8	30-31	a	_	_	
1-9	32-44	transgastric	_	_	
1-10	45-54	fastening	_	_	
1-11	55-63	assembly	_	_	
1-12	64-67	may	_	_	
1-13	68-70	be	_	_	
1-14	71-79	required	_	_	
1-15	80-82	at	_	_	
1-16	83-86	the	_	_	
1-17	87-93	region	_	_	
1-18	94-96	of	_	_	
1-19	97-100	the	_	_	
1-20	101-107	cardia	_	_	
1-21	108-111	402	_	_	
1-22	112-114	to	_	_	
1-23	115-120	treat	_	_	
1-24	121-127	morbid	_	_	
1-25	128-135	obesity	_	_	
1-26	136-138	in	_	_	
1-27	139-140	a	_	_	
1-28	141-148	similar	_	_	
1-29	149-155	manner	_	_	
1-30	156-158	to	_	_	
1-31	159-163	that	_	_	
1-32	164-172	utilized	_	_	
1-33	173-177	with	_	_	
1-34	178-181	the	_	_	
1-35	182-193	LAP-BAND.TM	_	_	
1-36	193-194	.	_	_	

#Text=(Inamed Corp., Santa Barbara, Calif.).
2-1	195-196	(	_	_	
2-2	196-202	Inamed	_	_	
2-3	203-207	Corp	_	_	
2-4	207-208	.	_	_	
2-5	208-209	,	_	_	
2-6	210-215	Santa	_	_	
2-7	216-223	Barbara	_	_	
2-8	223-224	,	_	_	
2-9	225-230	Calif	_	_	
2-10	230-231	.	_	_	
2-11	231-232	)	_	_	
2-12	232-233	.	_	_	

#Text=In this embodiment, the transgastric fastening assembly is not utilized to reduce the volume of the stomach, but to create a restriction to the inflow of food.
3-1	234-236	In	_	_	
3-2	237-241	this	_	_	
3-3	242-252	embodiment	_	_	
3-4	252-253	,	_	_	
3-5	254-257	the	_	_	
3-6	258-270	transgastric	_	_	
3-7	271-280	fastening	_	_	
3-8	281-289	assembly	_	_	
3-9	290-292	is	_	_	
3-10	293-296	not	_	_	
3-11	297-305	utilized	_	_	
3-12	306-308	to	_	_	
3-13	309-315	reduce	_	_	
3-14	316-319	the	_	_	
3-15	320-326	volume	_	_	
3-16	327-329	of	_	_	
3-17	330-333	the	_	_	
3-18	334-341	stomach	_	_	
3-19	341-342	,	_	_	
3-20	343-346	but	_	_	
3-21	347-349	to	_	_	
3-22	350-356	create	_	_	
3-23	357-358	a	_	_	
3-24	359-370	restriction	_	_	
3-25	371-373	to	_	_	
3-26	374-377	the	_	_	
3-27	378-384	inflow	_	_	
3-28	385-387	of	_	_	
3-29	388-392	food	_	_	
3-30	392-393	.	_	_	

#Text=In this embodiment, the fastening system can traverse the cardia but does not necessarily completely oppose the mucosal surfaces of the anterior and posterior walls of the stomach.
4-1	394-396	In	_	_	
4-2	397-401	this	_	_	
4-3	402-412	embodiment	_	_	
4-4	412-413	,	_	_	
4-5	414-417	the	_	_	
4-6	418-427	fastening	_	_	
4-7	428-434	system	_	_	
4-8	435-438	can	_	_	
4-9	439-447	traverse	_	_	
4-10	448-451	the	_	_	
4-11	452-458	cardia	_	_	
4-12	459-462	but	_	_	
4-13	463-467	does	_	_	
4-14	468-471	not	_	_	
4-15	472-483	necessarily	_	_	
4-16	484-494	completely	_	_	
4-17	495-501	oppose	_	_	
4-18	502-505	the	_	_	
4-19	506-513	mucosal	_	_	
4-20	514-522	surfaces	_	_	
4-21	523-525	of	_	_	
4-22	526-529	the	_	_	
4-23	530-538	anterior	_	_	
4-24	539-542	and	_	_	
4-25	543-552	posterior	_	_	
4-26	553-558	walls	_	_	
4-27	559-561	of	_	_	
4-28	562-565	the	_	_	
4-29	566-573	stomach	_	_	
4-30	573-574	.	_	_	

#Text=In some embodiments, the transgastric assemblies do in fact completely appose the walls of the stomach together but allow food to pass through by not completely traversing the cardia, leaving a space for flow of food stuffs.
5-1	575-577	In	_	_	
5-2	578-582	some	_	_	
5-3	583-594	embodiments	_	_	
5-4	594-595	,	_	_	
5-5	596-599	the	_	_	
5-6	600-612	transgastric	_	_	
5-7	613-623	assemblies	_	_	
5-8	624-626	do	_	_	
5-9	627-629	in	_	_	
5-10	630-634	fact	_	_	
5-11	635-645	completely	_	_	
5-12	646-652	appose	_	_	
5-13	653-656	the	_	_	
5-14	657-662	walls	_	_	
5-15	663-665	of	_	_	
5-16	666-669	the	_	_	
5-17	670-677	stomach	_	_	
5-18	678-686	together	_	_	
5-19	687-690	but	_	_	
5-20	691-696	allow	_	_	
5-21	697-701	food	_	_	
5-22	702-704	to	_	_	
5-23	705-709	pass	_	_	
5-24	710-717	through	_	_	
5-25	718-720	by	_	_	
5-26	721-724	not	_	_	
5-27	725-735	completely	_	_	
5-28	736-746	traversing	_	_	
5-29	747-750	the	_	_	
5-30	751-757	cardia	_	_	
5-31	757-758	,	_	_	
5-32	759-766	leaving	_	_	
5-33	767-768	a	_	_	
5-34	769-774	space	_	_	
5-35	775-778	for	_	_	
5-36	779-783	flow	_	_	
5-37	784-786	of	_	_	
5-38	787-791	food	_	_	
5-39	792-798	stuffs	_	_	
5-40	798-799	.	_	_	

#Text=The assembly can further be configured to provide electrical signals to the anterior and/or posterior portions of the stomach in this region.
6-1	800-803	The	_	_	
6-2	804-812	assembly	_	_	
6-3	813-816	can	_	_	
6-4	817-824	further	_	_	
6-5	825-827	be	_	_	
6-6	828-838	configured	_	_	
6-7	839-841	to	_	_	
6-8	842-849	provide	_	_	
6-9	850-860	electrical	_	_	
6-10	861-868	signals	_	_	
6-11	869-871	to	_	_	
6-12	872-875	the	_	_	
6-13	876-884	anterior	_	_	
6-14	885-888	and	_	_	
6-15	888-889	/	_	_	
6-16	889-891	or	_	_	
6-17	892-901	posterior	_	_	
6-18	902-910	portions	_	_	
6-19	911-913	of	_	_	
6-20	914-917	the	_	_	
6-21	918-925	stomach	_	_	
6-22	926-928	in	_	_	
6-23	929-933	this	_	_	
6-24	934-940	region	_	_	
6-25	940-941	.	_	_	

#Text=The active region of this embodiment can be quite large, in some cases ranging up to 10-15 cm, large enough to traverse almost the entire width of the cardia.
#Text=[0193] In another embodiment, the disclosed methods in combination with the transgastric fastening assemblies can be adapted to attach a gastrointestinal organ to the abdominal wall which, in addition to reducing volume, can also create a kink in the organ (e.g. the stomach).
7-1	942-945	The	_	_	
7-2	946-952	active	_	_	
7-3	953-959	region	_	_	
7-4	960-962	of	_	_	
7-5	963-967	this	_	_	
7-6	968-978	embodiment	_	_	
7-7	979-982	can	_	_	
7-8	983-985	be	_	_	
7-9	986-991	quite	_	_	
7-10	992-997	large	_	_	
7-11	997-998	,	_	_	
7-12	999-1001	in	_	_	
7-13	1002-1006	some	_	_	
7-14	1007-1012	cases	_	_	
7-15	1013-1020	ranging	_	_	
7-16	1021-1023	up	_	_	
7-17	1024-1026	to	_	_	
7-18	1027-1029	10	_	_	
7-19	1029-1030	-	_	_	
7-20	1030-1032	15	_	_	
7-21	1033-1035	cm	_	_	
7-22	1035-1036	,	_	_	
7-23	1037-1042	large	_	_	
7-24	1043-1049	enough	_	_	
7-25	1050-1052	to	_	_	
7-26	1053-1061	traverse	_	_	
7-27	1062-1068	almost	_	_	
7-28	1069-1072	the	_	_	
7-29	1073-1079	entire	_	_	
7-30	1080-1085	width	_	_	
7-31	1086-1088	of	_	_	
7-32	1089-1092	the	_	_	
7-33	1093-1099	cardia	_	_	
7-34	1099-1100	.	_	_	
7-35	1101-1102	[	_	_	
7-36	1102-1106	0193	_	_	
7-37	1106-1107	]	_	_	
7-38	1108-1110	In	_	_	
7-39	1111-1118	another	_	_	
7-40	1119-1129	embodiment	_	_	
7-41	1129-1130	,	_	_	
7-42	1131-1134	the	_	_	
7-43	1135-1144	disclosed	_	_	
7-44	1145-1152	methods	_	_	
7-45	1153-1155	in	_	_	
7-46	1156-1167	combination	_	_	
7-47	1168-1172	with	_	_	
7-48	1173-1176	the	_	_	
7-49	1177-1189	transgastric	_	_	
7-50	1190-1199	fastening	_	_	
7-51	1200-1210	assemblies	_	_	
7-52	1211-1214	can	_	_	
7-53	1215-1217	be	_	_	
7-54	1218-1225	adapted	_	_	
7-55	1226-1228	to	_	_	
7-56	1229-1235	attach	_	_	
7-57	1236-1237	a	_	_	
7-58	1238-1254	gastrointestinal	_	_	
7-59	1255-1260	organ	_	_	
7-60	1261-1263	to	_	_	
7-61	1264-1267	the	_	_	
7-62	1268-1277	abdominal	_	_	
7-63	1278-1282	wall	_	_	
7-64	1283-1288	which	_	_	
7-65	1288-1289	,	_	_	
7-66	1290-1292	in	_	_	
7-67	1293-1301	addition	_	_	
7-68	1302-1304	to	_	_	
7-69	1305-1313	reducing	_	_	
7-70	1314-1320	volume	_	_	
7-71	1320-1321	,	_	_	
7-72	1322-1325	can	_	_	
7-73	1326-1330	also	_	_	
7-74	1331-1337	create	_	_	
7-75	1338-1339	a	_	_	
7-76	1340-1344	kink	_	_	
7-77	1345-1347	in	_	_	
7-78	1348-1351	the	_	_	
7-79	1352-1357	organ	_	_	
7-80	1358-1359	(	_	_	
7-81	1359-1362	e.g	_	_	
7-82	1362-1363	.	_	_	
7-83	1364-1367	the	_	_	
7-84	1368-1375	stomach	_	_	
7-85	1375-1376	)	_	_	
7-86	1376-1377	.	_	_	

#Text=The kink may cause a resistance barrier (in addition to volume reduction) to gastrointestinal contents and can be useful to treat reflux disease or morbid obesity.
8-1	1378-1381	The	_	_	
8-2	1382-1386	kink	_	_	
8-3	1387-1390	may	_	_	
8-4	1391-1396	cause	_	_	
8-5	1397-1398	a	_	_	
8-6	1399-1409	resistance	_	_	
8-7	1410-1417	barrier	_	_	
8-8	1418-1419	(	_	_	
8-9	1419-1421	in	_	_	
8-10	1422-1430	addition	_	_	
8-11	1431-1433	to	_	_	
8-12	1434-1440	volume	_	_	
8-13	1441-1450	reduction	_	_	
8-14	1450-1451	)	_	_	
8-15	1452-1454	to	_	_	
8-16	1455-1471	gastrointestinal	_	_	
8-17	1472-1480	contents	_	_	
8-18	1481-1484	and	_	_	
8-19	1485-1488	can	_	_	
8-20	1489-1491	be	_	_	
8-21	1492-1498	useful	_	_	
8-22	1499-1501	to	_	_	
8-23	1502-1507	treat	_	_	
8-24	1508-1514	reflux	_	_	
8-25	1515-1522	disease	_	_	
8-26	1523-1525	or	_	_	
8-27	1526-1532	morbid	_	_	
8-28	1533-1540	obesity	_	_	
8-29	1540-1541	.	_	_	

#Text=Such a kink would also fix the gastrointestinal region to the abdominal wall as well as maintain the reduction of a hiatal hernia in the abdominal compartment (e.g. in reflux disease).
9-1	1542-1546	Such	_	_	
9-2	1547-1548	a	_	_	
9-3	1549-1553	kink	_	_	
9-4	1554-1559	would	_	_	
9-5	1560-1564	also	_	_	
9-6	1565-1568	fix	_	_	
9-7	1569-1572	the	_	_	
9-8	1573-1589	gastrointestinal	_	_	
9-9	1590-1596	region	_	_	
9-10	1597-1599	to	_	_	
9-11	1600-1603	the	_	_	
9-12	1604-1613	abdominal	_	_	
9-13	1614-1618	wall	_	_	
9-14	1619-1621	as	_	_	
9-15	1622-1626	well	_	_	
9-16	1627-1629	as	_	_	
9-17	1630-1638	maintain	_	_	
9-18	1639-1642	the	_	_	
9-19	1643-1652	reduction	_	_	
9-20	1653-1655	of	_	_	
9-21	1656-1657	a	_	_	
9-22	1658-1664	hiatal	_	_	
9-23	1665-1671	hernia	_	_	
9-24	1672-1674	in	_	_	
9-25	1675-1678	the	_	_	
9-26	1679-1688	abdominal	_	_	
9-27	1689-1700	compartment	_	_	
9-28	1701-1702	(	_	_	
9-29	1702-1705	e.g	_	_	
9-30	1705-1706	.	_	_	
9-31	1707-1709	in	_	_	
9-32	1710-1716	reflux	_	_	
9-33	1717-1724	disease	_	_	
9-34	1724-1725	)	_	_	
9-35	1725-1726	.	_	_	

#Text=A major component of reflux disease is a hiatal hernia in which the gastroesophageal junction freely slides from the abdomen to the mediastinum.
10-1	1727-1728	A	_	_	
10-2	1729-1734	major	_	_	
10-3	1735-1744	component	_	_	
10-4	1745-1747	of	_	_	
10-5	1748-1754	reflux	_	_	
10-6	1755-1762	disease	_	_	
10-7	1763-1765	is	_	_	
10-8	1766-1767	a	_	_	
10-9	1768-1774	hiatal	_	_	
10-10	1775-1781	hernia	_	_	
10-11	1782-1784	in	_	_	
10-12	1785-1790	which	_	_	
10-13	1791-1794	the	_	_	
10-14	1795-1811	gastroesophageal	_	_	
10-15	1812-1820	junction	_	_	
10-16	1821-1827	freely	_	_	
10-17	1828-1834	slides	_	_	
10-18	1835-1839	from	_	_	
10-19	1840-1843	the	_	_	
10-20	1844-1851	abdomen	_	_	
10-21	1852-1854	to	_	_	
10-22	1855-1858	the	_	_	
10-23	1859-1870	mediastinum	_	_	
10-24	1870-1871	.	_	_	

#Text=A percutaneously placed suture or anchor in the region of the gastric cardia and/or fundus can tether the junction to the abdominal wall and confine the junction to the abdomen.
#Text=[0194] In other embodiments, the devices and methods of this invention can assist in the implantation of devices such as stents, meshes, stitches, or tubes in the gastrointestinal tract.
11-1	1872-1873	A	_	_	
11-2	1874-1888	percutaneously	_	_	
11-3	1889-1895	placed	_	_	
11-4	1896-1902	suture	_	_	
11-5	1903-1905	or	_	_	
11-6	1906-1912	anchor	_	_	
11-7	1913-1915	in	_	_	
11-8	1916-1919	the	_	_	
11-9	1920-1926	region	_	_	
11-10	1927-1929	of	_	_	
11-11	1930-1933	the	_	_	
11-12	1934-1941	gastric	_	_	
11-13	1942-1948	cardia	_	_	
11-14	1949-1952	and	_	_	
11-15	1952-1953	/	_	_	
11-16	1953-1955	or	_	_	
11-17	1956-1962	fundus	_	_	
11-18	1963-1966	can	_	_	
11-19	1967-1973	tether	_	_	
11-20	1974-1977	the	_	_	
11-21	1978-1986	junction	_	_	
11-22	1987-1989	to	_	_	
11-23	1990-1993	the	_	_	
11-24	1994-2003	abdominal	_	_	
11-25	2004-2008	wall	_	_	
11-26	2009-2012	and	_	_	
11-27	2013-2020	confine	_	_	
11-28	2021-2024	the	_	_	
11-29	2025-2033	junction	_	_	
11-30	2034-2036	to	_	_	
11-31	2037-2040	the	_	_	
11-32	2041-2048	abdomen	_	_	
11-33	2048-2049	.	_	_	
11-34	2050-2051	[	_	_	
11-35	2051-2055	0194	_	_	
11-36	2055-2056	]	_	_	
11-37	2057-2059	In	_	_	
11-38	2060-2065	other	_	_	
11-39	2066-2077	embodiments	_	_	
11-40	2077-2078	,	_	_	
11-41	2079-2082	the	_	_	
11-42	2083-2090	devices	_	_	
11-43	2091-2094	and	_	_	
11-44	2095-2102	methods	_	_	
11-45	2103-2105	of	_	_	
11-46	2106-2110	this	_	_	
11-47	2111-2120	invention	_	_	
11-48	2121-2124	can	_	_	
11-49	2125-2131	assist	_	_	
11-50	2132-2134	in	_	_	
11-51	2135-2138	the	_	_	
11-52	2139-2151	implantation	_	_	
11-53	2152-2154	of	_	_	
11-54	2155-2162	devices	_	_	
11-55	2163-2167	such	_	_	
11-56	2168-2170	as	_	_	
11-57	2171-2177	stents	_	_	
11-58	2177-2178	,	_	_	
11-59	2179-2185	meshes	_	_	
11-60	2185-2186	,	_	_	
11-61	2187-2195	stitches	_	_	
11-62	2195-2196	,	_	_	
11-63	2197-2199	or	_	_	
11-64	2200-2205	tubes	_	_	
11-65	2206-2208	in	_	_	
11-66	2209-2212	the	_	_	
11-67	2213-2229	gastrointestinal	_	_	
11-68	2230-2235	tract	_	_	
11-69	2235-2236	.	_	_	

#Text=A major technical difficulty encountered in placing stents, tubes, balloons, stimulators, and meshes inside the lumen of the gastrointestinal tract is that they tend to migrate because the walls of such devices do not adhere to slippery mucosa.
12-1	2237-2238	A	*[1]	13-15[2_1]	
12-2	2239-2244	major	*[1]	_	
12-3	2245-2254	technical	*[1]	_	
12-4	2255-2265	difficulty	*[1]	_	
12-5	2266-2277	encountered	*[1]	_	
12-6	2278-2280	in	*[1]	_	
12-7	2281-2288	placing	*[1]	_	
12-8	2289-2295	stents	*[1]	_	
12-9	2295-2296	,	*[1]	_	
12-10	2297-2302	tubes	*[1]	_	
12-11	2302-2303	,	*[1]	_	
12-12	2304-2312	balloons	*[1]	_	
12-13	2312-2313	,	*[1]	_	
12-14	2314-2325	stimulators	*[1]	_	
12-15	2325-2326	,	*[1]	_	
12-16	2327-2330	and	*[1]	_	
12-17	2331-2337	meshes	*[1]	_	
12-18	2338-2344	inside	*[1]	_	
12-19	2345-2348	the	*[1]	_	
12-20	2349-2354	lumen	*[1]	_	
12-21	2355-2357	of	*[1]	_	
12-22	2358-2361	the	*[1]	_	
12-23	2362-2378	gastrointestinal	*[1]	_	
12-24	2379-2384	tract	*[1]	_	
12-25	2385-2387	is	*[1]	_	
12-26	2388-2392	that	*[1]	_	
12-27	2393-2397	they	*[1]	_	
12-28	2398-2402	tend	*[1]	_	
12-29	2403-2405	to	*[1]	_	
12-30	2406-2413	migrate	*[1]	_	
12-31	2414-2421	because	*[1]	_	
12-32	2422-2425	the	*[1]	_	
12-33	2426-2431	walls	*[1]	_	
12-34	2432-2434	of	*[1]	_	
12-35	2435-2439	such	*[1]	_	
12-36	2440-2447	devices	*[1]	_	
12-37	2448-2450	do	*[1]	_	
12-38	2451-2454	not	*[1]	_	
12-39	2455-2461	adhere	*[1]	_	
12-40	2462-2464	to	*[1]	_	
12-41	2465-2473	slippery	*[1]	_	
12-42	2474-2480	mucosa	*[1]	_	
12-43	2480-2481	.	*[1]	_	

#Text=A transgastric or transintestinal anchor, implanted with the current instrumentation, could solve this problem.
13-1	2482-2483	A	_	_	
13-2	2484-2496	transgastric	_	_	
13-3	2497-2499	or	_	_	
13-4	2500-2515	transintestinal	_	_	
13-5	2516-2522	anchor	_	_	
13-6	2522-2523	,	_	_	
13-7	2524-2533	implanted	_	_	
13-8	2534-2538	with	_	_	
13-9	2539-2542	the	_	_	
13-10	2543-2550	current	_	_	
13-11	2551-2566	instrumentation	_	_	
13-12	2566-2567	,	_	_	
13-13	2568-2573	could	_	_	
13-14	2574-2579	solve	_	_	
13-15	2580-2584	this	*[2]	_	
13-16	2585-2592	problem	*[2]	_	
13-17	2592-2593	.	_	_	

#Text=Such a method would be particularly useful in the attachment of the stent part of the stent-sleeve system outlined in patent application US20050075622A1, or the mesh of patent application US20040172141A1.
14-1	2594-2598	Such	_	_	
14-2	2599-2600	a	_	_	
14-3	2601-2607	method	_	_	
14-4	2608-2613	would	_	_	
14-5	2614-2616	be	_	_	
14-6	2617-2629	particularly	_	_	
14-7	2630-2636	useful	_	_	
14-8	2637-2639	in	_	_	
14-9	2640-2643	the	_	_	
14-10	2644-2654	attachment	_	_	
14-11	2655-2657	of	_	_	
14-12	2658-2661	the	_	_	
14-13	2662-2667	stent	_	_	
14-14	2668-2672	part	_	_	
14-15	2673-2675	of	_	_	
14-16	2676-2679	the	_	_	
14-17	2680-2692	stent-sleeve	_	_	
14-18	2693-2699	system	_	_	
14-19	2700-2708	outlined	_	_	
14-20	2709-2711	in	_	_	
14-21	2712-2718	patent	_	_	
14-22	2719-2730	application	_	_	
14-23	2731-2746	US20050075622A1	_	_	
14-24	2746-2747	,	_	_	
14-25	2748-2750	or	_	_	
14-26	2751-2754	the	_	_	
14-27	2755-2759	mesh	_	_	
14-28	2760-2762	of	_	_	
14-29	2763-2769	patent	_	_	
14-30	2770-2781	application	_	_	
14-31	2782-2797	US20040172141A1	_	_	
14-32	2797-2798	.	_	_	

#Text=In another example, devices such as those disclosed in U.S.
15-1	2799-2801	In	_	_	
15-2	2802-2809	another	_	_	
15-3	2810-2817	example	_	_	
15-4	2817-2818	,	_	_	
15-5	2819-2826	devices	_	_	
15-6	2827-2831	such	_	_	
15-7	2832-2834	as	_	_	
15-8	2835-2840	those	_	_	
15-9	2841-2850	disclosed	_	_	
15-10	2851-2853	in	_	_	
15-11	2854-2857	U.S	_	_	
15-12	2857-2858	.	_	_	

#Text=Pat.
16-1	2859-2862	Pat	_	_	
16-2	2862-2863	.	_	_	

#Text=No. 6773441 attempt to place an endoscopic stitch to tether the cardia of the stomach to the fundus to treat reflux disease.
17-1	2864-2866	No	_	_	
17-2	2866-2867	.	_	_	
17-3	2868-2875	6773441	_	_	
17-4	2876-2883	attempt	_	_	
17-5	2884-2886	to	_	_	
17-6	2887-2892	place	_	_	
17-7	2893-2895	an	_	_	
17-8	2896-2906	endoscopic	_	_	
17-9	2907-2913	stitch	_	_	
17-10	2914-2916	to	_	_	
17-11	2917-2923	tether	_	_	
17-12	2924-2927	the	_	_	
17-13	2928-2934	cardia	_	_	
17-14	2935-2937	of	_	_	
17-15	2938-2941	the	_	_	
17-16	2942-2949	stomach	_	_	
17-17	2950-2952	to	_	_	
17-18	2953-2956	the	_	_	
17-19	2957-2963	fundus	_	_	
17-20	2964-2966	to	_	_	
17-21	2967-2972	treat	_	_	
17-22	2973-2979	reflux	_	_	
17-23	2980-2987	disease	_	_	
17-24	2987-2988	.	_	_	

#Text=Such stitches are tenuous in the long term because they do not necessarily penetrate the serosa.
18-1	2989-2993	Such	_	_	
18-2	2994-3002	stitches	_	_	
18-3	3003-3006	are	_	_	
18-4	3007-3014	tenuous	_	_	
18-5	3015-3017	in	_	_	
18-6	3018-3021	the	_	_	
18-7	3022-3026	long	_	_	
18-8	3027-3031	term	_	_	
18-9	3032-3039	because	_	_	
18-10	3040-3044	they	_	_	
18-11	3045-3047	do	_	_	
18-12	3048-3051	not	_	_	
18-13	3052-3063	necessarily	_	_	
18-14	3064-3073	penetrate	_	_	
18-15	3074-3077	the	_	_	
18-16	3078-3084	serosa	_	_	
18-17	3084-3085	.	_	_	

#Text=Even if the stitches penetrate the serosa, they tend to erode through the wall with time because of their thin profile and an inability of the endoscopic operator to control tension on the suture when it is placed.
19-1	3086-3090	Even	_	_	
19-2	3091-3093	if	_	_	
19-3	3094-3097	the	_	_	
19-4	3098-3106	stitches	_	_	
19-5	3107-3116	penetrate	_	_	
19-6	3117-3120	the	_	_	
19-7	3121-3127	serosa	_	_	
19-8	3127-3128	,	_	_	
19-9	3129-3133	they	_	_	
19-10	3134-3138	tend	_	_	
19-11	3139-3141	to	_	_	
19-12	3142-3147	erode	_	_	
19-13	3148-3155	through	_	_	
19-14	3156-3159	the	_	_	
19-15	3160-3164	wall	_	_	
19-16	3165-3169	with	_	_	
19-17	3170-3174	time	_	_	
19-18	3175-3182	because	_	_	
19-19	3183-3185	of	_	_	
19-20	3186-3191	their	_	_	
19-21	3192-3196	thin	_	_	
19-22	3197-3204	profile	_	_	
19-23	3205-3208	and	_	_	
19-24	3209-3211	an	_	_	
19-25	3212-3221	inability	_	_	
19-26	3222-3224	of	_	_	
19-27	3225-3228	the	_	_	
19-28	3229-3239	endoscopic	_	_	
19-29	3240-3248	operator	_	_	
19-30	3249-3251	to	_	_	
19-31	3252-3259	control	_	_	
19-32	3260-3267	tension	_	_	
19-33	3268-3270	on	_	_	
19-34	3271-3274	the	_	_	
19-35	3275-3281	suture	_	_	
19-36	3282-3286	when	_	_	
19-37	3287-3289	it	_	_	
19-38	3290-3292	is	_	_	
19-39	3293-3299	placed	_	_	
19-40	3299-3300	.	_	_	

#Text=With the methods and devices of this invention, such an endoscopic suture can be buttressed with a percutaneously placed anchor.
#Text=[0195] Although the described methods are focused on the implantation of transgastric fastening assemblies to reduce the volume of the stomach or to increase the resistance to the flow of food in the stomach, the methods and devices can easily be expanded to the implantation of other types of devices such as neurostimulators, gastric muscle stimulators, gastric balloons, and bulking devices inside the wall of a gastrointestinal organ using the percutaneous procedures and devices described herein.
#Text=[0196] The methods disclosed herein (e.g. the percutaneous procedure) can further be used to apply an energy source to an internal organ without having to give general anesthesia or pneumoperitoneum.
20-1	3301-3305	With	_	_	
20-2	3306-3309	the	_	_	
20-3	3310-3317	methods	_	_	
20-4	3318-3321	and	_	_	
20-5	3322-3329	devices	_	_	
20-6	3330-3332	of	_	_	
20-7	3333-3337	this	_	_	
20-8	3338-3347	invention	_	_	
20-9	3347-3348	,	_	_	
20-10	3349-3353	such	_	_	
20-11	3354-3356	an	_	_	
20-12	3357-3367	endoscopic	_	_	
20-13	3368-3374	suture	_	_	
20-14	3375-3378	can	_	_	
20-15	3379-3381	be	_	_	
20-16	3382-3392	buttressed	_	_	
20-17	3393-3397	with	_	_	
20-18	3398-3399	a	_	_	
20-19	3400-3414	percutaneously	_	_	
20-20	3415-3421	placed	_	_	
20-21	3422-3428	anchor	_	_	
20-22	3428-3429	.	_	_	
20-23	3430-3431	[	_	_	
20-24	3431-3435	0195	_	_	
20-25	3435-3436	]	_	_	
20-26	3437-3445	Although	_	_	
20-27	3446-3449	the	_	_	
20-28	3450-3459	described	_	_	
20-29	3460-3467	methods	_	_	
20-30	3468-3471	are	_	_	
20-31	3472-3479	focused	_	_	
20-32	3480-3482	on	_	_	
20-33	3483-3486	the	_	_	
20-34	3487-3499	implantation	_	_	
20-35	3500-3502	of	_	_	
20-36	3503-3515	transgastric	_	_	
20-37	3516-3525	fastening	_	_	
20-38	3526-3536	assemblies	_	_	
20-39	3537-3539	to	_	_	
20-40	3540-3546	reduce	_	_	
20-41	3547-3550	the	_	_	
20-42	3551-3557	volume	_	_	
20-43	3558-3560	of	_	_	
20-44	3561-3564	the	_	_	
20-45	3565-3572	stomach	_	_	
20-46	3573-3575	or	_	_	
20-47	3576-3578	to	_	_	
20-48	3579-3587	increase	_	_	
20-49	3588-3591	the	_	_	
20-50	3592-3602	resistance	_	_	
20-51	3603-3605	to	_	_	
20-52	3606-3609	the	_	_	
20-53	3610-3614	flow	_	_	
20-54	3615-3617	of	_	_	
20-55	3618-3622	food	_	_	
20-56	3623-3625	in	_	_	
20-57	3626-3629	the	_	_	
20-58	3630-3637	stomach	_	_	
20-59	3637-3638	,	_	_	
20-60	3639-3642	the	_	_	
20-61	3643-3650	methods	_	_	
20-62	3651-3654	and	_	_	
20-63	3655-3662	devices	_	_	
20-64	3663-3666	can	_	_	
20-65	3667-3673	easily	_	_	
20-66	3674-3676	be	_	_	
20-67	3677-3685	expanded	_	_	
20-68	3686-3688	to	_	_	
20-69	3689-3692	the	_	_	
20-70	3693-3705	implantation	_	_	
20-71	3706-3708	of	_	_	
20-72	3709-3714	other	_	_	
20-73	3715-3720	types	_	_	
20-74	3721-3723	of	_	_	
20-75	3724-3731	devices	_	_	
20-76	3732-3736	such	_	_	
20-77	3737-3739	as	_	_	
20-78	3740-3756	neurostimulators	_	_	
20-79	3756-3757	,	_	_	
20-80	3758-3765	gastric	_	_	
20-81	3766-3772	muscle	_	_	
20-82	3773-3784	stimulators	_	_	
20-83	3784-3785	,	_	_	
20-84	3786-3793	gastric	_	_	
20-85	3794-3802	balloons	_	_	
20-86	3802-3803	,	_	_	
20-87	3804-3807	and	_	_	
20-88	3808-3815	bulking	_	_	
20-89	3816-3823	devices	_	_	
20-90	3824-3830	inside	_	_	
20-91	3831-3834	the	_	_	
20-92	3835-3839	wall	_	_	
20-93	3840-3842	of	_	_	
20-94	3843-3844	a	_	_	
20-95	3845-3861	gastrointestinal	_	_	
20-96	3862-3867	organ	_	_	
20-97	3868-3873	using	_	_	
20-98	3874-3877	the	_	_	
20-99	3878-3890	percutaneous	_	_	
20-100	3891-3901	procedures	_	_	
20-101	3902-3905	and	_	_	
20-102	3906-3913	devices	_	_	
20-103	3914-3923	described	_	_	
20-104	3924-3930	herein	_	_	
20-105	3930-3931	.	_	_	
20-106	3932-3933	[	_	_	
20-107	3933-3937	0196	_	_	
20-108	3937-3938	]	_	_	
20-109	3939-3942	The	_	_	
20-110	3943-3950	methods	_	_	
20-111	3951-3960	disclosed	_	_	
20-112	3961-3967	herein	_	_	
20-113	3968-3969	(	_	_	
20-114	3969-3972	e.g	_	_	
20-115	3972-3973	.	_	_	
20-116	3974-3977	the	_	_	
20-117	3978-3990	percutaneous	_	_	
20-118	3991-4000	procedure	_	_	
20-119	4000-4001	)	_	_	
20-120	4002-4005	can	_	_	
20-121	4006-4013	further	_	_	
20-122	4014-4016	be	_	_	
20-123	4017-4021	used	_	_	
20-124	4022-4024	to	_	_	
20-125	4025-4030	apply	_	_	
20-126	4031-4033	an	_	_	
20-127	4034-4040	energy	_	_	
20-128	4041-4047	source	_	_	
20-129	4048-4050	to	_	_	
20-130	4051-4053	an	_	_	
20-131	4054-4062	internal	_	_	
20-132	4063-4068	organ	_	_	
20-133	4069-4076	without	_	_	
20-134	4077-4083	having	_	_	
20-135	4084-4086	to	_	_	
20-136	4087-4091	give	_	_	
20-137	4092-4099	general	_	_	
20-138	4100-4110	anesthesia	_	_	
20-139	4111-4113	or	_	_	
20-140	4114-4130	pneumoperitoneum	_	_	
20-141	4130-4131	.	_	_	

#Text=For example, the methods and devices of the current invention can be used to apply radiofrequency probes, microwave probes, ultrasound probes, and radioactive probes (to the serosa) in similar ways as disclosed in U.S.
21-1	4132-4135	For	_	_	
21-2	4136-4143	example	_	_	
21-3	4143-4144	,	_	_	
21-4	4145-4148	the	_	_	
21-5	4149-4156	methods	_	_	
21-6	4157-4160	and	_	_	
21-7	4161-4168	devices	_	_	
21-8	4169-4171	of	_	_	
21-9	4172-4175	the	_	_	
21-10	4176-4183	current	_	_	
21-11	4184-4193	invention	_	_	
21-12	4194-4197	can	_	_	
21-13	4198-4200	be	_	_	
21-14	4201-4205	used	_	_	
21-15	4206-4208	to	_	_	
21-16	4209-4214	apply	_	_	
21-17	4215-4229	radiofrequency	_	_	
21-18	4230-4236	probes	_	_	
21-19	4236-4237	,	_	_	
21-20	4238-4247	microwave	_	_	
21-21	4248-4254	probes	_	_	
21-22	4254-4255	,	_	_	
21-23	4256-4266	ultrasound	_	_	
21-24	4267-4273	probes	_	_	
21-25	4273-4274	,	_	_	
21-26	4275-4278	and	_	_	
21-27	4279-4290	radioactive	_	_	
21-28	4291-4297	probes	_	_	
21-29	4298-4299	(	_	_	
21-30	4299-4301	to	_	_	
21-31	4302-4305	the	_	_	
21-32	4306-4312	serosa	_	_	
21-33	4312-4313	)	_	_	
21-34	4314-4316	in	_	_	
21-35	4317-4324	similar	_	_	
21-36	4325-4329	ways	_	_	
21-37	4330-4332	as	_	_	
21-38	4333-4342	disclosed	_	_	
21-39	4343-4345	in	_	_	
21-40	4346-4349	U.S	_	_	
21-41	4349-4350	.	_	_	

#Text=Pat.
22-1	4351-4354	Pat	_	_	
22-2	4354-4355	.	_	_	

#Text=No. 6,872,206.
23-1	4356-4358	No	_	_	
23-2	4358-4359	.	_	_	
23-3	4360-4369	6,872,206	_	_	
23-4	4369-4370	.	_	_	

#Text=The energy sources can be temporary or permanent and can be activated remotely through the abdominal wall in the case where they are implantable.
24-1	4371-4374	The	_	_	
24-2	4375-4381	energy	_	_	
24-3	4382-4389	sources	_	_	
24-4	4390-4393	can	_	_	
24-5	4394-4396	be	_	_	
24-6	4397-4406	temporary	_	_	
24-7	4407-4409	or	_	_	
24-8	4410-4419	permanent	_	_	
24-9	4420-4423	and	_	_	
24-10	4424-4427	can	_	_	
24-11	4428-4430	be	_	_	
24-12	4431-4440	activated	_	_	
24-13	4441-4449	remotely	_	_	
24-14	4450-4457	through	_	_	
24-15	4458-4461	the	_	_	
24-16	4462-4471	abdominal	_	_	
24-17	4472-4476	wall	_	_	
24-18	4477-4479	in	_	_	
24-19	4480-4483	the	_	_	
24-20	4484-4488	case	_	_	
24-21	4489-4494	where	_	_	
24-22	4495-4499	they	_	_	
24-23	4500-4503	are	_	_	
24-24	4504-4515	implantable	_	_	
24-25	4515-4516	.	_	_	

#Text=The methods can further be used for diagnostic purposes prior to performing a surgical therapy.
25-1	4517-4520	The	_	_	
25-2	4521-4528	methods	_	_	
25-3	4529-4532	can	_	_	
25-4	4533-4540	further	_	_	
25-5	4541-4543	be	_	_	
25-6	4544-4548	used	_	_	
25-7	4549-4552	for	_	_	
25-8	4553-4563	diagnostic	_	_	
25-9	4564-4572	purposes	_	_	
25-10	4573-4578	prior	_	_	
25-11	4579-4581	to	_	_	
25-12	4582-4592	performing	_	_	
25-13	4593-4594	a	_	_	
25-14	4595-4603	surgical	_	_	
25-15	4604-4611	therapy	_	_	
25-16	4611-4612	.	_	_	

#Text=In one example, the methods and devices are used to identify specific nerves or nerve plexuses prior to delivering a specific therapy.
26-1	4613-4615	In	_	_	
26-2	4616-4619	one	_	_	
26-3	4620-4627	example	_	_	
26-4	4627-4628	,	_	_	
26-5	4629-4632	the	_	_	
26-6	4633-4640	methods	_	_	
26-7	4641-4644	and	_	_	
26-8	4645-4652	devices	_	_	
26-9	4653-4656	are	_	_	
26-10	4657-4661	used	_	_	
26-11	4662-4664	to	_	_	
26-12	4665-4673	identify	_	_	
26-13	4674-4682	specific	_	_	
26-14	4683-4689	nerves	_	_	
26-15	4690-4692	or	_	_	
26-16	4693-4698	nerve	_	_	
26-17	4699-4707	plexuses	_	_	
26-18	4708-4713	prior	_	_	
26-19	4714-4716	to	_	_	
26-20	4717-4727	delivering	_	_	
26-21	4728-4729	a	_	_	
26-22	4730-4738	specific	_	_	
26-23	4739-4746	therapy	_	_	
26-24	4746-4747	.	_	_	

#Text=In another example, specific hormone producing regions, such as ghrelin, are identified prior to delivering a specific therapy.
27-1	4748-4750	In	_	_	
27-2	4751-4758	another	_	_	
27-3	4759-4766	example	_	_	
27-4	4766-4767	,	_	_	
27-5	4768-4776	specific	_	_	
27-6	4777-4784	hormone	_	_	
27-7	4785-4794	producing	_	_	
27-8	4795-4802	regions	_	_	
27-9	4802-4803	,	_	_	
27-10	4804-4808	such	_	_	
27-11	4809-4811	as	_	_	
27-12	4812-4819	ghrelin	_	_	
27-13	4819-4820	,	_	_	
27-14	4821-4824	are	_	_	
27-15	4825-4835	identified	_	_	
27-16	4836-4841	prior	_	_	
27-17	4842-4844	to	_	_	
27-18	4845-4855	delivering	_	_	
27-19	4856-4857	a	_	_	
27-20	4858-4866	specific	_	_	
27-21	4867-4874	therapy	_	_	
27-22	4874-4875	.	_	_	

#Text=Following the methods and devices outlined both above and below, instruments can be placed in the abdominal cavity under percutaneous guidance.
28-1	4876-4885	Following	_	_	
28-2	4886-4889	the	_	_	
28-3	4890-4897	methods	_	_	
28-4	4898-4901	and	_	_	
28-5	4902-4909	devices	_	_	
28-6	4910-4918	outlined	_	_	
28-7	4919-4923	both	_	_	
28-8	4924-4929	above	_	_	
28-9	4930-4933	and	_	_	
28-10	4934-4939	below	_	_	
28-11	4939-4940	,	_	_	
28-12	4941-4952	instruments	_	_	
28-13	4953-4956	can	_	_	
28-14	4957-4959	be	_	_	
28-15	4960-4966	placed	_	_	
28-16	4967-4969	in	_	_	
28-17	4970-4973	the	_	_	
28-18	4974-4983	abdominal	_	_	
28-19	4984-4990	cavity	_	_	
28-20	4991-4996	under	_	_	
28-21	4997-5009	percutaneous	_	_	
28-22	5010-5018	guidance	_	_	
28-23	5018-5019	.	_	_	

#Text=Any of the layers of the stomach can be accessed and stimulation, ablation, or diagnostic devices can subsequently be placed without anesthesia and without pneumoperitoneum.
29-1	5020-5023	Any	_	_	
29-2	5024-5026	of	_	_	
29-3	5027-5030	the	_	_	
29-4	5031-5037	layers	_	_	
29-5	5038-5040	of	_	_	
29-6	5041-5044	the	_	_	
29-7	5045-5052	stomach	_	_	
29-8	5053-5056	can	_	_	
29-9	5057-5059	be	_	_	
29-10	5060-5068	accessed	_	_	
29-11	5069-5072	and	_	_	
29-12	5073-5084	stimulation	_	_	
29-13	5084-5085	,	_	_	
29-14	5086-5094	ablation	_	_	
29-15	5094-5095	,	_	_	
29-16	5096-5098	or	_	_	
29-17	5099-5109	diagnostic	_	_	
29-18	5110-5117	devices	_	_	
29-19	5118-5121	can	_	_	
29-20	5122-5134	subsequently	_	_	
29-21	5135-5137	be	_	_	
29-22	5138-5144	placed	_	_	
29-23	5145-5152	without	_	_	
29-24	5153-5163	anesthesia	_	_	
29-25	5164-5167	and	_	_	
29-26	5168-5175	without	_	_	
29-27	5176-5192	pneumoperitoneum	_	_	
29-28	5192-5193	.	_	_	

#Text=For example, a stimulation device can be placed in any layer of the stomach wall such as the serosa or muscular layers for example.
30-1	5194-5197	For	_	_	
30-2	5198-5205	example	_	_	
30-3	5205-5206	,	_	_	
30-4	5207-5208	a	_	_	
30-5	5209-5220	stimulation	_	_	
30-6	5221-5227	device	_	_	
30-7	5228-5231	can	_	_	
30-8	5232-5234	be	_	_	
30-9	5235-5241	placed	_	_	
30-10	5242-5244	in	_	_	
30-11	5245-5248	any	_	_	
30-12	5249-5254	layer	_	_	
30-13	5255-5257	of	_	_	
30-14	5258-5261	the	_	_	
30-15	5262-5269	stomach	_	_	
30-16	5270-5274	wall	_	_	
30-17	5275-5279	such	_	_	
30-18	5280-5282	as	_	_	
30-19	5283-5286	the	_	_	
30-20	5287-5293	serosa	_	_	
30-21	5294-5296	or	_	_	
30-22	5297-5305	muscular	_	_	
30-23	5306-5312	layers	_	_	
30-24	5313-5316	for	_	_	
30-25	5317-5324	example	_	_	
30-26	5324-5325	.	_	_	
